Results 301 to 310 of about 739,943 (342)

Laws and Ethics Affecting Clinical Trials in Africa [PDF]

, 2017
Barnes, Mark, Wallace, Nick
core   +1 more source

Association of DNA damage response pathway genes with rheumatoid arthritis risks: a case-control study. [PDF]

Sci Rep
Hussain MZ, Khan MH, Haris MS, Huzaira R, Munawar A, Haq MFU, Shafique R, Mahjabeen I.   +7 more
europepmc   +1 more source

Risk of new-onset and recurrent uveitis with different biologics for ankylosing spondylitis: a network meta-analysis. [PDF]

Front Immunol
Zhao X, Xie Q, He X, Lu Y, Li M, Shuai S.   +5 more
europepmc   +1 more source

Some MSM Blood Donors Move from a Lifetime Deferral to a One Year Ban “Finally” or “Not Good Enough”? [PDF]

, 2018
Printz, Heather
core   +1 more source

Predicting Favorable Conditions for the Determination of Initial Use of Janus Kinase Inhibitors in Patients with Moderate to Severe Atopic Dermatitis. [PDF]

J Clin Med
Park JH, Oh S, Park J, Choi Y, Lee JH.
europepmc   +1 more source

Medicare spending and use of subcutaneous biologic formulations with hyaluronidase. [PDF]

Oncologist
Kim J, Kesselheim AS, Cliff ERS, Rome BN.   +3 more
europepmc   +1 more source

Safety and Efficacy of Intravenous Immune Globulin 10% (BIVIGAM^®) in Children with Primary Immune Deficiency. [PDF]

J Clin Immunol
Melamed I, Walter JE, Alpan O, BIVI 994 Authors, Leiding JW.   +4 more
europepmc   +1 more source

Matching placebo development for injectable biologics-a practical tutorial. [PDF]

Antib Ther
Xin L, Zhang Z, Shah K, Hashemi V, Li X, Qin G, Ren S, Chen W, Li Y.   +8 more
europepmc   +1 more source